Related Experiment Video
Updated: Mar 20, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
APPL1-mediated activation of STAT3 contributes to inhibitory effect of adiponectin on hepatic gluconeogenesis
Youming Ding1, Deling Zhang2, Bin Wang1
1Department of Hepatobiliary & Laparoscopic Surgery, Wuhan University Renmin Hospital, Wuhan 430060, China.
Abstract:
Adiponectin has been shown to suppress hepatic gluconeogenesis. However, the signaling pathways underlying its action remain ill-defined. The purpose of this study was to examine the potential role of APPL1 in mediating anti-gluconeogenic ability of adiponectin. Primary hepatocytes were isolated from male C57BL/6 mice. Western blot and RT-PCR were performed to detect protein expression and mRNA level, respectively. The protein-protein association was determined by immunoprecipitation and GST pull-down assay. We found that APPL1 protein levels were negatively associated with expressions of proteins and mRNAs of gluconeogenesis enzymes under stimulation with adiponectin. In addition, adiponectin-stimulated STAT3 phosphorylation and acetylation were positively regulated by APPL1 and negative regulated by SirT1. Pharmacological and genetic inhibition of STAT3 mitigated impact of adiponectin on hepatic gluconeogenesis. Furthermore, adiponectin administration facilitated the binding of APPL1 to SirT1 and suppressed the association of SirT1 with STAT3. Taken together, our study showed that APPL1-SirT1-STAT3 pathway mediated adiponectin signaling in primary hepatocytes. This new finding provides a novel mechanism by which adiponectin suppresses hepatic gluconeogenesis.
Insights
Adiponectin suppresses liver glucose production via the APPL1-SirT1-STAT3 pathway. This study reveals how adiponectin signaling regulates gluconeogenesis in hepatocytes.
Area of Science:
- Metabolism
- Cell Signaling
- Hormone Action
Background:
- Adiponectin is known to inhibit hepatic gluconeogenesis.
- The precise molecular mechanisms and signaling pathways involved are not fully understood.
Purpose of the Study:
- To investigate the role of APPL1 (Adapter Protein Containing Pleckstrin Homology Domain, Clathrin-Binding Site, and Leucine Repeats) in mediating adiponectin's anti-gluconeogenic effects.
- To elucidate the signaling cascade involving APPL1, SirT1, and STAT3 in adiponectin action.
Main Methods:
- Primary hepatocytes were isolated from male C57BL/6 mice.
- Western blot and RT-PCR were used to analyze protein and mRNA levels.
- Immunoprecipitation and GST pull-down assays assessed protein-protein interactions.
Main Results:
- APPL1 levels correlated inversely with gluconeogenic enzyme expression upon adiponectin stimulation.
- APPL1 positively regulated adiponectin-induced STAT3 phosphorylation and acetylation, while SirT1 negatively regulated it.
- Inhibition of STAT3 abolished adiponectin's effect on hepatic gluconeogenesis.
- Adiponectin enhanced APPL1-SirT1 binding and reduced SirT1-STAT3 association.
Conclusions:
- The APPL1-SirT1-STAT3 pathway is a key mediator of adiponectin signaling in primary hepatocytes.
- This pathway provides a novel molecular mechanism for how adiponectin suppresses hepatic gluconeogenesis.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression

